EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Initial clinical results with the Amplatzer Septal Occluder: A self-centering double-disc device for the occlusion of atrial septal defects



Initial clinical results with the Amplatzer Septal Occluder: A self-centering double-disc device for the occlusion of atrial septal defects



Zeitschrift fuer Kardiologie 87(3): 185-190, March



In recent years many different systems for transcatheter closure of an atrial septal defect (ASD) have been developed and tested. However, all systems presently available have some special disadvantages. The recently introduced Amplatzer Septal Occluder (ASO), though, appears promising. It is a self-expanding and self-centering double disc made from a Nitinol mesh, which is tightly woven to give mechanical strength. Both discs are separated by a connecting cylindrical portion. Its diameter may be chosen, so that it corresponds to that of the ASD. Discs of polyester patches are sewn into the retention discs as well as into the cylindrical portion of the device in order to augment thrombogenicity. After measuring the diameter of the ASD with a balloon, an appropriate ASO is selected and advanced into the left atrium through a 7 or 8 French sheath. Then the distal disc and part of the connecting cylindrical portion is developed in the left atrium and pulled against the atrial septum, so that the cylindrical portion is occluding the ASD. Thereafter, proximal disc is deployed and the delivery cable disconnected. As long as the cable is connected to the device repositioning is easily achieved by pulling the device back into the sheath. Within a time period of 4 months in 29 out of 31 patients (median age: 12.1 years, median weight: 45.0 kg) complete closure of the ASD with a mean diameter of 11.0 mm (6-20 mm) was achieved without complications, the average fluoroscopy time being 8.3 min (2.9-21.5 min). Mean Qp:Qs was 1.5 (0.9-2.2). During a mean follow-up period of 2.1 months post implantation fixed seating of the ASO without residual shunt, arrhythmias, thrombembolic events and impairment of A-V valves was observed in all patients. Conclusion: The Amplatzer septal occluder allows quick, safe, and complete closure of atrial septal defects without complications if one adheres to strict implantation criteria. For a final judgement, however, long-term follow-up studies are necessary.

(PDF emailed within 1 workday: $29.90)

Accession: 008883595

Download citation: RISBibTeXText



Related references

Initial clinical results with the Amplatzer septal occluder--a self-centering double disc for occlusion of atrial septal defects. Zeitschrift für Kardiologie 87(3): 185-190, 1998

Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Catheterization and Cardiovascular Diagnosis 42(4): 388-393, 1997

Transcatheter occlusion of atrial septal defects: An initial experience with the Amplatzer septal occluder. Journal of Paediatrics & Child Health 34(4): 369-373, 1998

Transcatheter closure of secundum atrial septal defects with the new self-centering Amplatzer Septal Occluder. European Heart Journal 20(7): 541-549, April, 1999

Transcatheter closure of multiple atrial septal defects using two amplatzer septal occluder devices Initial results. Circulation 98(17 SUPPL ): I414, Oct 27, 1998

Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience. Heart 82(3): 300-306, 1999

Successful transcatheter retrieval of a large dislocated Amplatzer septal occluder and re-occlusion of the atrial septal defect by Amplatzer septal occluder: a case report. Zhonghua Xin Xue Guan Bing Za Zhi 37(7): 655-656, 2010

Figulla ASD occluder versus Amplatzer Septal Occluder: a comparative study on validation of a novel device for percutaneous closure of atrial septal defects. Journal of Interventional Cardiology 22(6): 489-495, 2011

Transcatheter closure of secundum atrial septal defects using the new nitinol self-expandable, repositionable Amplatzer septal occluder Initial clinical experience. Circulation. 96(8 Suppl.): I568, 10 21 97, 1997

Clinical results of percutaneous closure of large secundum atrial septal defects in children using the Amplatzer septal occluder. Heart and Vessels 23(3): 187-192, 2008

Transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder Results of phase II US multicenter clinical trial. Circulation 100(18 SUPPL ): I 804, Nov 2, 1999

Amplatzer septal occluder for catheter closure of large secundum atrial septal defects Results of international/US multicenter clinical trial. Journal of the American College of Cardiology 33(2 SUPPL A): 531A, 1999

Transcatheter occlusion of atrial septal defects with the Amplatzer septal occluder. European Heart Journal 19(ABST SUPPL ): 525, 1998